Motor Imaging, Neglect, and Upper Extremity Function in Stroke

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-80
SponsorInonu University

About this trial

This study aims to investigate the relationship between motor imagery skills and neglect level, upper extremity motor function, activities of daily living, quality of life, lateralization performance, and mental timer performance in individuals with stroke. Individuals with stroke who meet the inclusion criteria and voluntarily agree to participate will be evaluated. Demographic and clinical information of the participants will be recorded on an assessment form prepared by the researcher. Upper extremity motor functions will be assessed using the Fugl-Meyer Upper Extremity Motor Assessment Scale and the Wolf Motor Function Test; activities of daily living will be assessed using the Modified Barthel Index; and quality of life will be assessed using the Stroke-Specific Quality of Life Scale. Motor imagery skills will be measured using the Kinesthetic and Visual Imagery Questionnaire and a mental timer task; upper extremity lateralization performance will be assessed using the Recognise™ application. Neglect level will be assessed using the Catherine Bergego Scale, the Line Splitting Test, and the Star Erase Test. The data obtained will be statistically analyzed to examine the relationships between motor imagery skills and other clinical variables.

Eligibility criteria

Qualifiers

Individuals who have experienced hemiplegia after an ischemic stroke,

who actively use their right extremity according to the Edinburgh Hand Preference Questionnaire,

who have right hemisphere involvement,

who are 18 years of age or older,

Disqualifiers

Individuals with major neurological, orthopedic, or rheumatological disorders affecting upper extremity function other than stroke (Polyneuropathy, Parkinson's Disease, Multiple Sclerosis, Rheumatoid Arthritis, etc.),

Individuals with upper extremity amputation,

Individuals with uncontrolled arrhythmia, uncontrolled hypertension, or unstable cardiac conditions,

Individuals with active malignancy and receiving related chemo/radiotherapy,

Trial design

Treatments tested in this trial

  • No intervention will be made; an assessment will be conducted.

Treatment groups

50 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators